posted directly to operating margin through share of profit from joint ventures accounted for using equity method. All-in- all, there is no dilutive at operating margin to OSP beverage portfolio. - Q2’20

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

Revenues 8,770 6,755 446 322 9,216 7,077 2,139 30% Total Expenses (8,664) (6,715) (378) (292) (9,042) (7,007) 2,035 29% Share of Profit (Loss) 1,775 1,688 27 19 1,802 1,707 95 6% Gain on disposal of

8,016 5,337 2,679 50% Total Expenses (7,221) (4,956) (156) (126) (7,377) (5,082) 2,295 45% Share of Profit (Loss) 2,417 2,037 12 4 2,429 2,041 388 19% Profit (Loss) before FX, deferred income tax

1,586.14 -12.47 -0.8% Earning before interest and tax 65.39 90.65 -25.26 -27.9% 137.31 166.19 -28.88 -17.4% Financial expenses -1.30 -1.38 0.08 -5.8% -2.63 -3.03 0.40 -13.2% Share of income from investment

8,600 203 183 10,343 8,783 1,560 18% Total Expenses (9,082) (7,760) (180) (158) (9,262) (7,918) 1,344 17% Share of Profit (Loss) 1,446 2,127 22 25 1,468 2,152 (684) (32%) Profit (Loss) before the effects

, Greenwing Energy B.V., a wholly owned subsidiary of EGCO, entered into the share purchase agreement to acquire a 25% ownership interest in Yunlin Holding GmbH (Yunlin) owned by Taiwan Offshore Holding GmbH

in financing activities was THB 1,030mn mainly from proceeds from the increase in share capital of THB 2,040mn. However, this offset by a decrease in short-term as well as long-term loans from

from 2Q2017. As a final point, consolidated net profit in 2Q2018 accounted for THB 211.58 million or equal to EPS of THB 0.17 per share, or 57.15% down from 2Q2017. For capital structure of the Group, as

74.67 57.77 8.23 GP 251.48 24.86 238.28 25.33 13.20 5.54 EBITDA 159.88 15.81 159.88 17.00 - - EBIT 100.80 9.97 98.15 10.44 2.65 2.70 NP 79.64 7.87 76.71 8.16 2.93 3.82 EPS (Baht per Share) * 0.08 0.08